Immune checkpoint inhibitors targeting programmed cell death 1 (PD-1), programmed cell
death ligand-1 (PD-L1), and others have shown potent clinical efficacy and have …

Purpose Numerous publications during the COVID-19 pandemic recommended the use of
hypofractionated radiation therapy. This project assessed aggregate changes in the quality …

As the global COVID-19 pandemic escalates there is a need within radiation oncology to
work to support our patients in the best way possible. Measures are required to reduce …

Importance Evidence is lacking from randomized clinical trials to guide the optimal approach
for stereotactic ablative body radiotherapy (SABR) in patients with pulmonary …

Importance Stereotactic ablative radiotherapy (SABR) is used for treating lung tumors but
can cause toxic effects, including life-threatening damage to central structures …

Background and purpose Single-fraction stereotactic ablative radiotherapy (SABR) is an
effective treatment for early-stage lung cancer, but concerns remain about the accurate …

Lung cancer is managed using conventional therapies, including chemotherapy, radiation
therapy, or a combination of both. Each of these therapies has its own limitations, such as …

Simple Summary Adoption of single-fraction stereotactic body radiation therapy for lung
tumors has been limited among different institutions even during the coronavirus disease …

Background Clinical decision-making for patients with stage I lung cancer is complex. It
involves multiple options [lobectomy, segmentectomy, wedge, stereotactic body …

Clinical trials frequently include multiple end points that mature at different times. The initial
report, typically based on the primary end point, may be published when key planned co …